Commission and Commissioner Public Statements and Letters

Show: 20 | 50 | 100
Displaying 20 results
Displaying 141 - 160 of 669

Pages

Statement of Commissioners Chopra and Slaughter Regarding the Federal Trade Commission Report on the Use of Section 5 to Address Off-Patent Pharmaceutical Price Spikes

Regarding the Federal Trade Commission Report on the Use of Section 5 to Address Off-Patent Pharmaceutical Price Spikes

Date:
By: 
Rohit Chopra;
Rebecca Kelly Slaughter
application/pdf icon Statement of Commissioners Chopra and Slaughter Regarding the Federal Trade Commission Report on the Use of Section 5 to Address Off-Patent Pharmaceutical Price Spikes (68.34 KB)
FTC Report on Standalone Section 5 to Address High Pharmaceutical Drug and Biologic Prices

Dissenting Statement of Commissioner Rebecca Kelly Slaughter Regarding the Matters of Sandpiper/PiperGear and Patriot Puck

Date:
Matter Number:

182 3095

182 3113

By: 
Rebecca Kelly Slaughter
application/pdf icon Dissenting Statement of Commissioner Rebecca Kelly Slaughter Regarding the Matters of Sandpiper/PiperGear and Patriot Puck (70.84 KB)
Related Release:
FTC Approves Final Consents Settling Charges that Hockey Puck Seller, Companies Selling Recreational and Outdoor Equipment Made False ‘Made in USA’ Claims

Joint Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Concerning U.S. v. iSpring Water Systems, LLC. et al.

Date:
Matter Number:

172 3033

C4611

By: 
Noah Joshua Phillips;
Christine S. Wilson
application/pdf icon Joint Statement of Commissioners Phillips and Wilson Concerning U.S. v. iSpring Water Systems, LLC. et al. (22.14 KB)
Related Release:
Marketer of Water Filtration Systems to Pay $110,000 Civil Penalty for Deceptive Made-in-USA Advertisements in Violation of 2017 Order

Statement of Chairman Simons, Commissioner Phillips, and Commissioner Wilson Concerning the Proposed Acquisition of NxStage Medical, Inc. by Fresenius Medical Care AG & Co. KGaA

In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.

Date:
Matter Number:

171 0227

By: 
Joseph J. Simons;
Noah Joshua Phillips;
Christine S. Wilson
application/pdf icon Statement of Chairman Simons, Commissioner Phillips, and Commissioner Wilson Concerning the Proposed Acquisition of NxStage Medical, Inc. by Fresenius Medical Care AG & Co. KGaA (21.81 KB)
Related Release:
FTC Requires Fresenius Medical Care AG & KGaA and NxStage Medical, Inc. to Divest Bloodline Tubing Assets to B. Braun Medical, Inc. as a Condition of Merger

Statement of Commissioner Chopra In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.

In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.

Date:
Matter Number:

171 0227

By: 
Rohit Chopra
application/pdf icon Statement of Commissioner Chopra In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc. (59.97 KB)
Related Release:
FTC Requires Fresenius Medical Care AG & KGaA and NxStage Medical, Inc. to Divest Bloodline Tubing Assets to B. Braun Medical, Inc. as a Condition of Merger

Statement of Commissioner Slaughter In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.

In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.

Date:
Matter Number:

171 0227

By: 
Rebecca Kelly Slaughter
application/pdf icon Statement of Commissioner Slaughter In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc. (47.96 KB)
Related Release:
FTC Requires Fresenius Medical Care AG & KGaA and NxStage Medical, Inc. to Divest Bloodline Tubing Assets to B. Braun Medical, Inc. as a Condition of Merger

Pages